Related Experiment Video

Updated: May 6, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion

Yi Liu1, Minghui Li, Guoqing Zhang

  • 1Department of Thoracic Surgery, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830011, China. gq_zhang2@126.com.

European Journal of Medical Research
|November 13, 2013
PubMed
Abstract

Insights

MicroRNA-10b (miR-10b) enhances non-small cell lung cancer (NSCLC) progression by increasing cell proliferation, migration, and invasion. This suggests miR-10b could be a therapeutic target for NSCLC treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression and implicated in human diseases.
  • The specific role of microRNA-10b (miR-10b) in non-small cell lung cancer (NSCLC) pathogenesis remains largely uncharacterized.
  • Understanding miR-10b's function in NSCLC is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional role of miR-10b in non-small cell lung cancer (NSCLC).
  • To determine the effect of miR-10b on NSCLC cell proliferation, migration, invasion, cell cycle, and apoptosis.
  • To identify potential molecular targets of miR-10b in NSCLC.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess miR-10b expression in NSCLC cell line A549.
  • Cell Counting Kit (CCK-8) assay for cell viability.
  • Wound healing and Transwell assays for cell migration and invasion.
  • Cell cycle and apoptosis analyses.
  • Western blotting to predict miR-10b targets.

Main Results:

  • Transfection with miR-10b significantly increased proliferation, migration, and invasion in A549 cells compared to controls (P < 0.05).
  • miR-10b may indirectly target Krüppel-like factor 4 (KLF4), potentially mediating its pro-proliferative effects in NSCLC.
  • miR-10b demonstrated a pro-tumorigenic role in the studied NSCLC cell line.

Conclusions:

  • miR-10b acts as a tumor enhancer in non-small cell lung cancer.
  • The findings highlight miR-10b as a potential therapeutic target for intervention in NSCLC.
  • Further research into miR-10b's regulatory mechanisms could lead to novel treatment strategies for NSCLC.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K